A Study of C-CAR066 in Subjects With r/r Diffuse Large B Cell Lymphoma Who Received CD19 CAR-T Therapy
Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
This is a single-center, non-randomized and dose-escalation study to evaluate the safety and
efficacy of C-CAR066 in treatment of r/r DLBCL who received CD19 CAR-T therapy.